Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide regimen comparison for edema in nephrotic syndrome
ChiCTR1900022533Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Shantou University Medical College
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of furosemide in nephrosis (2 arms), sponsored by The Second Affiliated Hospital of Shantou University Medical College. Primary endpoints: Urine volume and Body weight. Planned start May 2019; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR1900022533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022533.